SOTIO Biotech
Prague, Czechia · Health and Medical
Do your work at SOTIO Biotech?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
Jun 2026
Overview
SOTIO Biotech is shaping the future of cancer immunotherapies by translating compelling science into patient benefit. SOTIO’s robust clinical pipeline includes a differentiated superagonist of the attractive immuno-oncology target IL-15, a proprietary technology designed to improve on the efficacy of CAR T therapies and a new generation of potent and stable antibody-drug conjugates (ADCs). SOTIO is a member of the PPF Group.
Contact Details
+420224 175 111
media@sotio.com
Prague, Czechia, Českomoravská 2532/19b
+3
Founded
2010
Company Type
Private Limited Company
Employees
150-200
Keywords
You're invisible in searches for:
Add keywords that describe your company, services, or market to improve your visibility in search results.
Companies teams usually look at after SOTIO Biotech
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.